Registration Rights AgreementAphria Inc. • May 6th, 2021 • Medicinal chemicals & botanical products • New York
Aphria Inc., a corporation existing under the laws of the province of Ontario (the “Company”), proposes to issue and sell to the initial purchasers (the “Initial Purchasers”) listed in Schedule I of that certain Purchase Agreement dated April 17, 2019 (the “Purchase Agreement”) by and among the Company and Jefferies LLC, J.P. Morgan Securities LLC and Canaccord Genuity LLC, as representatives of the Initial Purchasers (“Representatives”), $300,000,000 aggregate principal amount of its 5.25% Convertible Senior Notes due 2024 (the “Initial Securities”), and at the election of the Initial Purchasers, up to an additional $50,000,000 aggregate principal amount of the Company’s 5.25% Convertible Senior Notes due 2024 (the “Option Securities” and, together with the Initial Securities, the “Securities”), in each case, upon the terms and subject to the conditions set forth in the Purchase Agreement.
